Profile: Heska Corp (HSKA.O)

HSKA.O on Consolidated Issue listed on NASDAQ Capital Market

22 May 2015
Change (% chg)

$0.01 (+0.03%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Heska Corporation, incorporated on March 27, 1997, develops, manufactures, markets, sells and supports veterinary products. The Company is focused on the canine and feline companion animal health markets. It operates in two segments: Core Companion Animal Health and Other Vaccines, Pharmaceuticals and Products. The Core Companion Animal Health segment (CCA) includes diagnostic instruments and supplies, as well as single use diagnostic and other tests, vaccines and pharmaceuticals, primarily for canine and feline use. These products are sold directly by the Company as well as through independent third-party distributors and through other distribution relationships. The Other Vaccines, Pharmaceuticals and Products segment (OVP) includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals and fish. All OVP products are sold by third parties under third party labels.

Core Companion Animal Health Segment

The Company offers a line of veterinary diagnostic and other instruments. It also markets and sells consumable supplies for these instruments. Its veterinary instruments include Blood Chemistry, Hematology, Blood Gases, Lactate and IV Pumps. The DRI-CHEM 4000 Veterinary Chemistry Analyzer (the DRI-CHEM 4000) is a robust system that uses dry slide technology for blood chemistry and electrolyte analysis and has the ability to run 22 tests at a time with a single blood sample. Test slides are available as both pre-packaged panels, as well as individual slides. The instrument has an additional feature allowing simple, fully automated sample dilution and results calculations. The DRI-CHEM 7000 Veterinary Chemistry Analyzer (the DRI-CHEM 7000), is a line extension of it chemistry offering with higher throughput, multiple patient staging and a STAT feature, which provides emergency sample flexibility in critical cases. The DRI-CHEM 7000 utilizes the same test slides as the DRI-CHEM 4000 and is manufactured by FUJIFILM. The HEMATRUE Veterinary Hematology Analyzer is an easy-to-use blood analyzer that measures such key parameters as white blood cell count, red blood cell count, platelet count and hemoglobin levels in animals. In addition, it continues to service and support its previous hematology instrument, the HESKA CBC-DIFF Veterinary Hematology System.

The Company is supplied new instruments and affiliated reagents and supplies of these products under a contractual agreement with Boule Medical AB (Boule). VitalPath delivers accurate results for blood gases, electrolytes, hematocrit and 27 additional calculated parameters in 50 seconds. The Accutrend Plus Lactate analyzer is a handheld, portable analyzer used to measure lactate. The VET/IV 2.2 infusion pump is a compact, affordable IV pump that allows veterinarians to easily provide regulated infusion of fluids, drugs or nutritional products for their patients. Its canine and feline heartworm diagnostic tests use monoclonal antibodies or a recombinant heartworm antigen, respectively, to detect heartworm antigens or antibodies circulating in the blood of an infected animal. The Company also markets and sells heartworm diagnostic tests for both dogs and cats. SOLO STEP CH for dogs and SOLO STEP FH for cats are available in point-of-care, single use formats that can be used by veterinarians on site. The Company also offers SOLO STEP CH Batch Test Strips, a rapid and simple point-of-care antigen detection test for dogs that allows veterinarians in larger practices to run multiple samples at the same time. It obtains SOLO STEP CH, SOLO STEP FH and SOLO STEP Batch Test Strips under a contractual agreement with Quidel Corporation (Quidel). Its ALLERCEPT Definitive Allergen Panels provide the determination, of which it is aware of the specific allergens to which an animal, such as a dog, cat or horse, is reacting. The test results serve as the basis for prescription ALLERCEPT Allergy Treatment Sets.

The Company sells kits to conduct blood testing using its ALLERCEPT Definitive Allergen Panels to third-party veterinary diagnostic laboratories outside of the United States. It also sells products to screen for the presence of allergen-specific IgE to these customers, the Company sells kits to conduct preliminary blood testing using products based on its ALLERCEPT Definitive Allergen Panels, as well as a similar test requiring less technical sophistication, its ALLERCEPT E-SCREEN Test. Animals testing positive for allergen-specific IgE using these screening tests are candidates for further evaluation using its ALLERCEPT Definitive Allergen Panels. The Company has veterinary diagnostic laboratories in Loveland, Colorado and Fribitsg, Switzerland which both offer blood testing using its ALLERCEPT Definitive Allergen Panels. The Company’s Loveland veterinary diagnostic laboratory also offers testing using its canine and feline heartworm, renal damage, immune status and flea bite allergy assays, as well as other diagnostic services including polymerase chain reaction, (PCR), based tests for certain infectious diseases.

TRI-HEART Plus Chewable Tablets (ivermectin/pyrantel) are indicated for use as a monthly preventive treatment of canine heartworm infection and for treatment and control of ascarid and hookworm infections. The Company manufactures TRI-HEART Plus Chewable Tablets at its Des Moines, Iowa production facility. The Company sells a fatty acid supplement, HESKA F.A. Granules. The sitsce of the fatty acids in this product, flaxseed oil, leads to high omega-3:omega-6 ratios of fatty acids. Diets high in omega-3 fatty acids are believed to lead to lower levels of inflammatory mediators. The HESKA F.A. Granules include vitamins and are formulated in a palatable flavor base that makes the product convenient and easy to administer. The Company sells a chewable thyroid supplement, THYROMED Chewable Tablets, for treatment of hypothyroidism in dogs. The Company offers canine, feline and equine subcutaneous immunotherapy treatment products. The Company sells FELINE ULTRANASAL FVRCP Vaccine a three-way modified live vaccine combination to prevent disease caused by the three most common respiratory viruses of cats: calicivirus, rhinotracheitis virus and panleukopenia virus.

Other Vaccines, Pharmaceuticals and Products Segment

The Company manufactures biological and pharmaceutical products for a number of other animal health companies. The Company manufactures products for animals including small mammals. Its offerings range from providing complete turnkey services which include research, licensing, production, labeling and packaging of products to providing any one of these services as needed by its customers, as well as validation support and distribution services. It has developed its own line of bovine vaccines that are licensed by the United States Department of Agriculture.

The Company competes with IDEXX Laboratories, Inc., Abaxis, Inc. Pfizer Inc. Bayer AG, CEVA Sante Animale, Eli Lilly and Company, Merck & Co., Inc., Novartis AG, Pfizer, sanofi-aventis, Vetoquinol S.A. and Virbac S.A.

Company Address

Heska Corp

3760 Rocky Mountain Avenue
LOVELAND   CO   80538
P: +1970.4937272
F: +1970.6193003

Company Web Links

Search Stocks